Abstract is: Michel Fardeau, born on 24 October 1929 in Paris 12th arrondissement, is a medical researcher in medical pathology, pioneering founder in France of myology, a medical discipline treating diseases of the neuromuscular system. He was also a full professor at the Conservatoire National des Arts et Métiers in a chair dedicated to the social integration of disabled people.
| human | Q5 |
| P5463 | AE member ID | Fardeau_Michel |
| P268 | Bibliothèque nationale de France ID | 11902250f |
| P973 | described at URL | https://www.inserm.fr/portrait/histoire/michel-fardeau/ |
| P6282 | French Academy of Sciences member ID | F/michel-fardeau |
| P2671 | Google Knowledge Graph ID | /g/11hdvdsnzt |
| P269 | IdRef ID | 026858045 |
| P213 | ISNI | 0000000000771287 |
| P11249 | KBR person ID | 14712850 |
| P244 | Library of Congress authority ID | n2017031550 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 08797536X |
| P214 | VIAF ID | 19677223 |
| P166 | award received | CNRS bronze medal | Q3332320 |
| P40 | child | Jean-Marie Fardeau | Q3167662 |
| P27 | country of citizenship | France | Q142 |
| P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
| P101 | field of work | myology | Q674407 |
| P735 | given name | Michel | Q14626626 |
| Michel | Q14626626 | ||
| P1412 | languages spoken, written or signed | French | Q150 |
| P463 | member of | Academia Europaea | Q337234 |
| P106 | occupation | physician | Q39631 |
| researcher | Q1650915 | ||
| P39 | position held | Director of Research at CNRS | Q3029430 |
| P21 | sex or gender | male | Q6581097 |
| P26 | spouse | Michèle Fardeau | Q124807497 |
| Q95384925 | Q95384925 |
| Q46196931 | "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy |
| Q80859056 | 121st ENMC International Workshop on Desmin and Protein Aggregate Myopathies. 7-9 November 2003, Naarden, The Netherlands |
| Q62672143 | 156th ENMC International Workshop: Desmin and protein aggregate myopathies, 9–11 November 2007, Naarden, The Netherlands |
| Q77316169 | 80th ENMC International Workshop on Multi-Minicore Disease: 1st International MmD Workshop. 12-13th May, 2000, Soestduinen, The Netherlands |
| Q34551830 | A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia. |
| Q39003495 | A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene |
| Q91284853 | ACTN2 mutations cause "Multiple structured Core Disease" (MsCD) |
| Q50008362 | About the technique of muscle biopsy (IV). The advent of histochemistry and cytoenzymology in the analysis of muscle biopsies. A short and personal historical overview |
| Q42466262 | Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations. |
| Q45869519 | Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues |
| Q74180066 | Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function |
| Q46943897 | Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister |
| Q34238168 | Autosomal dominant eccentric core disease caused by a heterozygous mutation in the MYH7 gene |
| Q48080069 | C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy |
| Q24305076 | COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps |
| Q48595183 | Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy |
| Q48012937 | Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia |
| Q28115358 | Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1 |
| Q92910346 | Clinical, histological, and genetic characterization of PYROXD1-related myopathy |
| Q47215034 | Congenital muscular dystrophy phenotype with neuromuscular spindles excess in a 5-year-old girl caused by HRAS mutation. |
| Q79554774 | Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies |
| Q28854559 | Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy |
| Q60472938 | Correction: A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia |
| Q40635064 | Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part I: rationale. |
| Q45889007 | Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part II: clinical protocol |
| Q45889011 | Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part III. Ethical considerations |
| Q53512507 | Cylindrical spirals associated with severe congenital muscle weakness and epileptic encephalopathy. |
| Q85122578 | De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins |
| Q53311250 | Desmin - Protein Surplus Myopathies, 96th European Neuromuscular Centre (ENMC)-sponsored International Workshop held 14-16 September 2001, Naarden, The Netherlands. |
| Q33977996 | Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. |
| Q38102239 | Diagnostic workup for neuromuscular diseases |
| Q45061374 | Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study. |
| Q39067296 | Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy |
| Q44560638 | Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia |
| Q81433406 | Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset |
| Q75382910 | EMG and nerve conduction studies in children with congenital muscular dystrophy |
| Q44363466 | Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. |
| Q44682405 | Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation. |
| Q39760999 | Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. |
| Q44551622 | Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency |
| Q37407306 | Extensive morphological and immunohistochemical characterization in myotubular myopathy. |
| Q89166849 | Genetic Mutations and Demographic, Clinical, and Morphological Aspects of Myofibrillar Myopathy in a French Cohort |
| Q74180058 | Glucocorticoid treatment induces expression of small heat shock proteins in human satellite cell populations: consequences for a desmin-related myopathy involving the R120G alpha B-crystallin mutation |
| Q60473840 | Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function |
| Q37301198 | Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. |
| Q45116927 | MUSK, a new target for mutations causing congenital myasthenic syndrome |
| Q34528684 | Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. |
| Q48120299 | Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy |
| Q28277269 | Mutations in dynamin 2 cause dominant centronuclear myopathy |
| Q22009039 | Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy |
| Q24617292 | Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies |
| Q38102244 | Myofibrillar myopathies. |
| Q42967735 | Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity |
| Q28247833 | Myotilinopathy in a family with late onset myopathy |
| Q36759458 | Natural history of LGMD2A for delineating outcome measures in clinical trials |
| Q87342675 | Neuromuscular disease: muscle |
| Q41956578 | PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling |
| Q46662240 | Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene |
| Q46767075 | Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome |
| Q40459778 | Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. |
| Q37450661 | Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. |
| Q54728720 | Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia. |
| Q40457545 | Protein 4.1R expression in normal and dystrophic skeletal muscle. |
| Q28115568 | RETRACTED: VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification |
| Q38950857 | Recessive MYPN mutations cause cap myopathy with occasional nemaline rods. |
| Q58036254 | Retraction Notice to: VMA21 Deficiency Causes an Autophagic Myopathy by Compromising V-ATPase Activity and Lysosomal Acidification |
| Q64044263 | Sarcomeric disorganization and nemaline bodies in muscle biopsies of patients with EXOSC3-related type 1 pontocerebellar hypoplasia |
| Q48595029 | Severe progressive form of congenital muscular dystrophy with calf pseudohypertrophy, macroglossia and respiratory insufficiency |
| Q37555776 | Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders |
| Q83237564 | Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation |
| Q37870328 | Telethonin-deficiency initially presenting as a congenital muscular dystrophy. |
| Q98470313 | The clinical, histological, and genotypic spectrum of SEPN1-related myopathy: A case series |
| Q28304113 | The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13 |
| Q34180176 | Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency |
| Q28283153 | VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy |
| Q54647465 | [About a phase I gene therapy clinical trial with a full-length dystrophin gene-plasmid in Duchenne/Becker muscular dystrophy]. |
| Q53285951 | [About the technique of muscle biopsy - A historical flash-back on the technique of muscle biopsie]. |
| Q85890711 | [Congenital myasthenic syndromes; French experience] |
| Q73001470 | [From clinical medicine to molecular genetics: the new outlook of hereditary muscular dystrophies] |
| Q80153585 | [Historical review on the researches on muscular dystrophies] |
| Q97367391 | Société française de myologie | founded by | P112 |
| Q3167662 | Jean-Marie Fardeau | father | P22 |
| Q124807497 | Michèle Fardeau | spouse | P26 |
| Egyptian Arabic (arz / Q29919) | ميشيل فارديو | wikipedia |
| Michel Fardeau | wikipedia | |
| Michel Fardeau | wikipedia |
Search more.